These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 183412)

  • 1. Vancomycin.
    Abou-Zeid AZ; Abd-el-Hamid M; Hassan AI
    Zentralbl Bakteriol Parasitenkd Infektionskr Hyg; 1976; 131(1):1-39. PubMed ID: 183412
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of a metronidazole-spiramycin association on anaerobic bacteria].
    Videau D
    Pathol Biol (Paris); 1971; 19(11):661-6. PubMed ID: 4326560
    [No Abstract]   [Full Text] [Related]  

  • 3. In-vitro comparison of the post-antibiotic effect of vancomycin and teicoplanin.
    Cooper MA; Jin YF; Ashby JP; Andrews JM; Wise R
    J Antimicrob Chemother; 1990 Aug; 26(2):203-7. PubMed ID: 2145256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus.
    Noble WC; Virani Z; Cree RG
    FEMS Microbiol Lett; 1992 Jun; 72(2):195-8. PubMed ID: 1505742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparative microbiological and pharmacokinetic activity of vancomycin and teicoplanin].
    Cohen R; Barre J; Varon E
    Pathol Biol (Paris); 1992 Oct; 40(8):831-44. PubMed ID: 1484744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of teichomycin A 2 in comparison with penicillin and vancomycin against gram-positive cocci.
    Bauernfeind A; Petermüller C
    Eur J Clin Microbiol; 1982 Oct; 1(5):278-81. PubMed ID: 6223812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Demonstration of an inoculum effect on the estimation of the minimal inhibitory concentration of LY 146032].
    Flandrois JP; Carret G; Pichat C; Peyret M
    Pathol Biol (Paris); 1988 May; 36(5):377-80. PubMed ID: 2841637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Vancomycin Susceptibility Testing Results for Presumptive Categorization of Telavancin.
    Mendes RE; Farrell DJ; Flamm RK; Sader HS; Jones RN
    J Clin Microbiol; 2015 Aug; 53(8):2727-30. PubMed ID: 26019194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro activity of daptomycin (LY146032) and vancomycin against gram-positive cocci determined using a pharmacokinetic model.
    Blenkharn JI; Darrell JH
    Eur J Clin Microbiol Infect Dis; 1989 Aug; 8(8):734-7. PubMed ID: 2550236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spiramycin, a macrolide antibiotic.
    Abou-Zeid AZ; Khalil A el-G ; Rabei M
    Zentralbl Bakteriol Naturwiss; 1980; 135(5):443-53. PubMed ID: 6779436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antibacterial action of vancomycin.
    Watanakunakorn C
    Rev Infect Dis; 1981; 3 suppl():S210-5. PubMed ID: 6805065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimicrobial effect of the new oral antidiabetic HB 419].
    Vömel W; Sauer W
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1491-4. PubMed ID: 4310120
    [No Abstract]   [Full Text] [Related]  

  • 13. The challenge of antibiotic resistance.
    Levy SB
    Sci Am; 1998 Mar; 278(3):46-53. PubMed ID: 9487702
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
    Barber KE; Smith JR; Raut A; Rybak MJ
    J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
    J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of human serum on the bactericidal activity of daptomycin and vancomycin against staphylococcal and enterococcal isolates as determined by time-kill kinetic studies.
    Stratton CW; Weeks LS
    Diagn Microbiol Infect Dis; 1990; 13(3):245-52. PubMed ID: 2166634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BE-24566B, a new antibiotic produced by Streptomyces violaceusniger.
    Kojiri K; Nakajima S; Fuse A; Suzuki H; Suda H
    J Antibiot (Tokyo); 1995 Dec; 48(12):1506-8. PubMed ID: 8557611
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria.
    Luther MK; Mermel LA; LaPlante KL
    Am J Health Syst Pharm; 2017 May; 74(9):e193-e201. PubMed ID: 28438824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of cadmium on indicator bacteria in sewage.
    Korkeala H; Hirn J
    Acta Vet Scand; 1980; 21(1):43-54. PubMed ID: 6247900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibacterial properties of the new unwoven band material biocell-NFA].
    Turovets' IG; Mikhnovs'ka ND; Babika AV; Fedorova LG; Kutsenok VA
    Mikrobiol Zh; 1975; 37(2):228-30. PubMed ID: 175250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.